Latest filing published 30 Jan 2025 for Apellis Pharmaceuticals, Inc., €10k.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Karen Lewis: trading record in brief
Karen Lewis (senior executive) discloses dealings in Apellis Pharmaceuticals, Inc. to SEC (Form 4). Between 28 January 2021 and 29 January 2025, the trades on record add up to 29 filings.
Sales make up the whole of the open-market record (15 sales, €1.9M). The rest of the record consists of 11 share grants and 2 option exercises. In 2025 alone, the filings show no purchases and 4 sales.
The latest filing, published on 30 January 2025, reports an open-market sale of €10k in Apellis Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Karen Lewis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 364 shares@ US$29.52360.8% of flowCommon StockSEC:0001127602-25-002381:0
- 1,751 shares@ US$30.42553.7% of flowCommon StockSEC:0001127602-25-001839:0
- 1,241 shares@ US$29.95822.6% of flowCommon StockSEC:0001127602-25-001623:0
- 28,508 shares0Common StockSEC:0001127602-25-001623:1
- 1,599 shares@ US$28.70213.3% of flowCommon StockSEC:0001127602-25-001200:0
- 367 shares@ US$64.13821.6% of flowCommon StockSEC:0001127602-24-002743:0
- 4,286 shares@ US$63.6918.3% of flowCommon StockSEC:0001127602-24-002017:0
- 1,738 shares@ US$64.9967.6% of flowCommon StockSEC:0001127602-24-001949:0
- 3,276 shares@ US$65.5814.4% of flowCommon StockSEC:0001127602-24-001601:0
- 16,963 shares0Common StockSEC:0001127602-24-001440:0
- 5,000 shares@ US$34.1111.6% of flowCommon StockSEC:0001127602-23-017568:0
- 5,000 shares@ US$34.1111.4% of flowCommon StockSEC:0001127602-23-012595:0
- 1,104 shares@ US$68.765.2% of flowCommon StockSEC:0001127602-23-007326:0
- 6,628 shares0Common StockSEC:0000899243-23-005790:0
- 883 shares@ US$52.763.1% of flowCommon StockSEC:0001127602-23-002750:0
- 367 shares@ US$52.771.3% of flowCommon StockSEC:0001127602-23-002686:0
- 2,955 shares@ US$51.5810.2% of flowCommon StockSEC:0001127602-23-002179:0
- 1,411 shares@ US$52.054.9% of flowCommon StockSEC:0001127602-23-002132:0
- 1,250 shares0Common StockSEC:0001127602-23-001498:0
- 19,634 shares0Common StockSEC:0001127602-23-001498:1
- 434 shares@ US$38.59100.0% of flowCommon StockSEC:0001127602-22-002805:0
- 17,466 shares0Common StockSEC:0001127602-22-002059:0
22 of 22 declarations
